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Purpose: Guidelines recommend that decision aids provide natural frequency data regarding baseline 
risk, risk reduction, and chances of false positives and negatives. Such quantitative information may 
confuse patients, especially those with low numeracy. We conducted a randomized trial to compare 
effects of 2 colorectal cancer (CRC) screening decision aids—one with and one without natural 
frequency data. 
Methods: 108 patients, aged 50–75 years, who were at average risk for CRC and due for screening were 
recruited from primary care clinics. All subjects viewed a CRC screening decision aid (without numbers), 
and half (n = 56) were randomized to view natural frequency data for 2 common screening tests. 
Participants completed questionnaires before and after viewing the decision aid that assessed subjective 
CRC risk, intent to be screened, and decisional conflict. At 6 months, screening behavior was assessed. 
Results: Members of both groups showed significant increases in subjective CRC risk, intent to be 
screened, intent to undergo fecal immunochemical testing (FIT), intent to undergo colonoscopy, and 
reduction in overall decisional conflict score (all P \ 0.01). However, no significant between-group 
differences in change scores were observed. 
Numeracy was a significant moderator. Among participants with numeracy scores higher than the 
median, those who viewed the natural frequency data had a significantly smaller increase in subjective 
CRC risk than those who did not view natural frequency data (20.09 v. 0.81, respectively, P = .009), and 
significantly greater intent to undergo FIT (1.00 v. 0.1, respectively, P = .01). However, for those with 
numeracy scores lower than the median, no significant between-group differences were seen. 
At 6 months, a higher proportion of patients who viewed the natural frequency data had completed CRC 
screening compared to those who did not; however, this difference was not significant (39.3% v. 26.9%, 
P = 0.173). Among patients with numeracy scores higher than the median, a higher uptake of FIT was 
observed among those who viewed the natural frequency data that approached significance (12.1% v. 
0%, P = 0.148); there were no significant between-group differences for those with below- median 
numeracy. 
Conclusions: Adding natural frequency data to a decision aid had a significant effect but only for patients 
with higher numeracy scores. More research is needed before making recommendations to present 
such data to all patients. 
